Evidence map›Paper›PMID 38762479›Full record

ArticleNature communications2024

Tlr9 deficiency in B cells leads to obesity by promoting inflammation and gut dysbiosis.

Pai Wang, Xin Yang, Luyao Zhang, Sha Sha, Juan Huang, Jian Peng, Jianlei Gu, James Alexander Pearson, Youjia Hu, Hongyu Zhao and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. B cells in non-lymphoid tissues.Nature reviews. Immunology · 2025
    Review
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Pai Wang *Department of Gastrocolorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China.ORCID http://orcid.org/0000-0002-6024-7588
Xin Yang *Section of Endocrinology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA.
Luyao ZhangDepartment of Gastrocolorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Sha ShaSection of Endocrinology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA.
Juan HuangSection of Endocrinology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA.
Jian PengSection of Endocrinology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA.
Jianlei GuDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
James Alexander PearsonSection of Endocrinology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-2867-2269
Youjia HuSection of Endocrinology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA.
Hongyu ZhaoDepartment of Biostatistics, Yale School of Public Health, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-1195-9607
F Susan WongDivision of Infection and Immunity, School of Medicine and Systems Immunity University Research Institute, Cardiff University, Cardiff, UK.
Quan WangDepartment of Gastrocolorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China. wquan@jlu.edu.cn.
Li WenSection of Endocrinology, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA. li.wen@yale.edu.ORCID http://orcid.org/0000-0002-8805-2934

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI GERALD I SHULMAN · 1993 to 2026
$44.0M
Antibody and gut bacteria in obesity and T2DR01DK126809 · NIDDK · YALE UNIVERSITY · PI WEN, LI · 2021 to 2024
$1.8M
Identifying immunoregulatory gut bacteria in type 1 diabetes and autoimmunityR01DK130318 · NIDDK · YALE UNIVERSITY · PI WEN, LI · 2022 to 2025
$1.6M
Investigating the early development of the immune system and islet autoimmunity later in lifeR01HD097808 · NICHD · YALE UNIVERSITY · PI WEN, LI · 2019 to 2021
$1.3M
Diabetes Action Research and Education Foundation (Diabetes Action) HD097808Medical Research Council MR/K021141/1Medical Research Council MR/T010525/1NCATS NIH HHS UL1 TR001863NICHD NIH HHS R01 HD097808NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK126809NIDDK NIH HHS R01 DK130318
6 · The paper itself

Abstract

Toll-like receptor 9 (TLR9) recognizes bacterial, viral and self DNA and play an important role in immunity and inflammation. However, the role of TLR9 in obesity is less well-studied. Here, we generate B-cell-specific Tlr9-deficient (Tlr9

Indexed as

B-LymphocytesDiet, High-FatDysbiosisGastrointestinal MicrobiomeInflammationInterleukin-10Mice, KnockoutObesityToll-Like Receptor 9AnimalsDisease Models, AnimalInterferon Regulatory Factor-4Interferon Regulatory FactorsMaleMiceMice, Inbred C57BLIL10 protein, mouseInterferon Regulatory Factor-4Interferon Regulatory FactorsInterleukin-10Tlr9 protein, mouseToll-Like Receptor 9

Identifiers

PMID38762479
PMCPMC11102548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.